Evermil 10mg Tablet | Everolimus 10mg | Afinitor Generic Buy Evermil 10mg Tablet online at the best price. A trusted targeted therapy for advanced kidney cancer, breast cancer, pancreatic tumors, and other cancers requiring Everolimus treatment. Product Overview Evermil 10mg Tablet contains Everolimus 10mg, a highly effective targeted therapy that works by inhibiting the mTOR (mammalian target of rapamycin) pathway. This mechanism helps slow down abnormal cancer cell growth and tumor progression. It is prescribed for the treatment of renal cell carcinoma (RCC), advanced breast cancer, pancreatic neuroendocrine tumors (pNET), and other rare tumors. Internationally, Everolimus is marketed under the trade name Afinitor. Evermil 10mg is a reliable and affordable alternative, offering the same therapeutic benefits at a cost-effective price. Key Features Active Ingredient: Everolimus 10mg Brand/Trade Name: Evermil 10mg / International Reference – Afinitor Form: Oral Tablet Strength: 10mg Administration: Oral, once daily (as prescribed by your doctor) Used For: Kidney cancer, breast cancer, pancreatic tumors, and other targeted cancer treatments SEO Keywords Integrated Evermil 10mg tablet Everolimus 10mg tablets buy Evermil 10mg online Afinitor generic Everolimus 10mg Everolimus 10mg price in India Everolimus cancer treatment tablet Evermil 10mg cost Everolimus 10mg buy online pharmacy Benefits Effective targeted therapy for advanced cancers Controls tumor growth via mTOR pathway inhibition Affordable generic alternative to Afinitor Widely prescribed in oncology treatment centers Convenient oral tablet form for daily use FAQs – Frequently Asked Questions Q1: What is Evermil 10mg Tablet used for? A: Evermil 10mg (Everolimus) is used in the treatment of renal cell carcinoma, breast cancer, pancreatic neuroendocrine tumors, and other cancers. Q2: How should I take Evermil 10mg? A: Evermil 10mg is taken orally, once daily, exactly as prescribed by your healthcare provider. Q3: Is Evermil 10mg the same as Afinitor? A: Yes, Evermil contains Everolimus 10mg, the same active ingredient as Afinitor, making it a trusted and cost-effective alternative. Q4: Can I buy Evermil 10mg online? A: Yes, you can buy Evermil 10mg Tablet online from trusted pharmacies and licensed medical suppliers at the best price. Q5: Why choose Evermil 10mg? A: It offers the same therapeutic effectiveness as Afinitor while being more affordable and accessible for patients worldwide. ✅ Order Now Buy Evermil 10mg Tablet (Everolimus 10mg, Afinitor Generic) online today at the best price with safe delivery to your doorstep.

Soranib (Sorafenib) 200 mg Company Name: Unnati Pharmax Product Overview Brand Name: Soranib Manufacturer / Company: Unnati Pharmax Active Ingredient: Sorafenib 200 mg Formulation: Film-coated tablet Country of Origin: India Therapeutic Uses Soranib (Sorafenib) is used in the treatment of: Liver cancer (Hepatocellular carcinoma) Advanced kidney cancer (Renal cell carcinoma) Certain types of thyroid cancer Mechanism of Action Sorafenib is an oral multi-kinase inhibitor that slows tumor growth and prevents the development of new blood vessels that feed cancer cells. Dosage & Administration Typical dose: 200 mg tablet, usually taken twice daily (as prescribed). Should be taken on an empty stomach – at least 1 hour before or 2 hours after meals. Side Effects Common side effects may include: Fatigue Nausea, diarrhea, weight loss Rash, skin irritation, hand-foot syndrome Abdominal discomfort Serious but less common side effects include: high blood pressure, bleeding, heart problems, or liver complications. Precautions Pregnancy & Breastfeeding: Not recommended. May cause harm to the unborn baby. Liver Impairment: Dose adjustment may be required. Drug Interactions: Inform your doctor about all other medications. Cardiovascular Risk: Regular monitoring of blood pressure and heart health is advised. Why Choose Unnati Pharmax’s Soranib? Manufactured under strict quality standards Specialized expertise in oncology medicines Trusted by healthcare professionals and patients globally